This company seems to have been delisted
Reason: Acquired by AbbVie
Last recorded trade on: April 12, 2024
Source: https://news.abbvie.com/2024-02-12-AbbVie-Completes-Acquisition-of-ImmunoGen
Reason: Acquired by AbbVie
Last recorded trade on: April 12, 2024
Source: https://news.abbvie.com/2024-02-12-AbbVie-Completes-Acquisition-of-ImmunoGen
ImmunoGen
IMGN
$43.30
Share price
0.00%
Change (1 day)
135.61%
Change (1 year)
Categories
P/S ratio for ImmunoGen (IMGN)
P/S ratio on April 12, 2024 (TTM) : 30.3
According to ImmunoGen 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 15.5. At the end of 2023 the company had a P/S ratio of 13.7.
P/S ratio history for ImmunoGen from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 13.7 | 36.47% |
| 2022 | 10.1 | -56.95% |
| 2021 | 23.4 | 146.29% |
| 2020 | 9.49 | 1.9% |
| 2019 | 9.32 | -30.57% |
| 2018 | 13.4 | 82.73% |
| 2017 | 7.34 | 65.72% |
| 2016 | 4.43 | -78.65% |
| 2015 | 20.8 | 192.92% |
| 2014 | 7.08 | -57.08% |
| 2013 | 16.5 | -80.15% |
| 2012 | 83.2 | 105.47% |
| 2011 | 40.5 | -1.53% |
| 2010 | 41.1 | 70.95% |
| 2009 | 24.0 | 281.05% |
| 2008 | 6.31 | 40.15% |
| 2007 | 4.50 | -19.89% |
| 2006 | 5.62 | -14.58% |
| 2005 | 6.58 | -36.27% |
| 2004 | 10.3 | -40.27% |
| 2003 | 17.3 | 2.2% |
| 2002 | 16.9 | -86.3% |
| 2001 | 123 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 18.8 | -38.15% | 🇺🇸 USA |
 | 4.61 | -84.80% | 🇺🇸 USA |
 | 14.5 | -52.08% | 🇺🇸 USA |
 | 2.14 | -92.96% | 🇺🇸 USA |
 | 4.11 | -86.46% | 🇺🇸 USA |
 | 1.95 | -93.57% | 🇺🇸 USA |
 | 4.11 | -86.46% | 🇨🇭 Switzerland |
 | 2.62 | -91.36% | 🇫🇷 France |